Back to top
more

Owens & Minor (OMI)

(Delayed Data from NYSE)

$11.80 USD

11.80
1,273,269

-0.20 (-1.67%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $11.51 -0.29 (-2.46%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Owens & Minor (OMI) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Owens & Minor (OMI) closed at $46.01, marking a -1.65% move from the previous day.

Owens & Minor (OMI) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Owens & Minor (OMI) closed at $46.90, marking a +1.16% move from the previous day.

Medtronic's (MDT) Q4 Earnings Beat Estimates, Margins Up

by Zacks Equity Research

Medtronic's (MDT) fourth-quarter results reflect a strong recovery in terms of elective procedures.

Why Owens & Minor (OMI) Isn't Done Growing Earnings Yet

by Zacks Equity Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Owens & Minor (OMI).

Strength Seen in Owens & Minor (OMI): Can Its 36.2% Jump Turn into More Strength?

by Zacks Equity Research

Owens & Minor (OMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

by Zacks Equity Research

Investors are optimistic about Exact Sciences (EXAS) on solid first-quarter performance and strategic partnerships.

Abbott (ABT) Organic Growth Strong, Pediatric Nutrition Down

by Zacks Equity Research

Within Medical Device, Abbott (ABT) is facing challenging conditions in terms of procedure volume.

Here's Why You Should Hold On to Zimmer Biomet (ZBH) Stock Now

by Zacks Equity Research

Investors are optimistic about Zimmer Biomet (ZBH) on solid first-quarter results and a gradually stabilizing global musculoskeletal market.

Kinjel Shah headshot

6 Valuable Price-to-Book Stocks to Boost Your Portfolio

by Kinjel Shah

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Top Ranked Growth Stocks to Buy for May 21st

by Zacks Equity Research

COLM, OMI, AN, and HRI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 21, 2021

Sumit Singh headshot

Add These 5 Low P/CF Stocks to Create a Value-Based Portfolio

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade Company (BCC), Vishay Intertechnology (VSH), Owens & Minor (OMI), Sanmina Corporation (SANM) and Invesco (IVZ) boast low P/CF ratio.

LabCorp's (LH) New Bioanalytical Lab to Boost APAC Operation

by Zacks Equity Research

The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.

Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal

by Zacks Equity Research

Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.

TeleFlex (TFX) Urolift Grows, Organic Sales Hit by Pandemic

by Zacks Equity Research

On the strength of a successful 2020 campaign, Teleflex (TFX) doubles the awareness for UroLift in the targeted population of men with BPH.

LabCorp's (LH) Pixel Kit Gets EUA for Younger Population

by Zacks Equity Research

LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.

Abbott (ABT) Receives CE Mark for Latest Navitor TAVI System

by Zacks Equity Research

Abbott's (ABT) latest-generation Navitor TAVI system features improvements to reduce or eliminate a backflow of blood around valve implants.

Here's Why You Should Buy Henry Schein (HSIC) Stock Now

by Zacks Equity Research

Investors are optimistic about Henry Schein (HSIC) on solid first-quarter performance and strategic deals.

Is Owens & Minor (OMI) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

New Strong Buy Stocks for May 17th

by Zacks Equity Research

AOSL, DIOD, LL, OMI, and RUSHA have been added to the Zacks Rank #1 (Strong Buy) List on May 17, 2021

Medtronic's (MDT) Coronary Market Share Grows Amid Pandemic

by Zacks Equity Research

In Gastrointestinal, Medtronic (MDT) is witnessing some modest share gains, driven in part by its partnership with the NHS in England.

Top Ranked Growth Stocks to Buy for May 17th

by Zacks Equity Research

LL, OMI, LB, and AN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 17, 2021

Top Ranked Value Stocks to Buy for May 17th

by Zacks Equity Research

AAWW, OMI, MCBS, and SBLK made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 17, 2021

Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now

by Zacks Equity Research

Investors continue to be optimistic about Tandem Diabetes (TNDM) on strong quarterly results and robust pump sales.

Tandem (TNDM) Global Growth Strong, Costs Continue to Rise

by Zacks Equity Research

Tandem Diabetes (TNDM) is witnessing high international demand for the t:slim X2 pump.

Here's Why You Should Buy Amedisys (AMED) Stock Now

by Zacks Equity Research

Investors are optimistic about Amedisys (AMED) on bright Personal Care prospects, and strategic acquisitions and partnerships.